News
SBMFF
0.778
NaN%
--
Sino Biopharm’s Long-Acting Ropivacaine Analgesic Wins NDA Acceptance in China
TipRanks · 1d ago
UBS Keeps Their Buy Rating on Sino Biopharmaceutical (SBMFF)
TipRanks · 1d ago
Weekly Report: what happened at SBMFF last week (0622-0626)?
Weekly Report · 5d ago
Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)
TipRanks · 6d ago
Sino Biopharmaceutical Wins Priority Review for CLDN18.2 Gastric Cancer Drug
TipRanks · 06/23 08:39
Sino Biopharmaceutical Wins China Approval for First-in-Class Peceleganan Spray
TipRanks · 06/23 08:38
Weekly Report: what happened at SBMFF last week (0615-0619)?
Weekly Report · 06/22 10:10
Sino Biopharmaceutical Adds Leading Scientists to Board as Independent Directors
TipRanks · 06/17 10:52
Sino Biopharmaceutical Details Board Composition and Governance Committee Roles
TipRanks · 06/17 10:51
Sino Biopharmaceutical Wins Strong Shareholder Backing at 2026 AGM
TipRanks · 06/17 10:10
Sino Biopharm’s ST2 Antibody Shows Promising Phase II Results in Allergic Rhinitis
TipRanks · 06/15 23:12
Weekly Report: what happened at SBMFF last week (0608-0612)?
Weekly Report · 06/15 10:11
Sino Biopharmaceutical Unveils HK$2 Billion Share Purchase Plan to Support Stock and Shareholders
TipRanks · 06/14 22:07
Weekly Report: what happened at SBMFF last week (0601-0605)?
Weekly Report · 06/08 10:07
Sino Biopharm’s Culmerciclib Shows Promise in Resistant Breast Cancer
TipRanks · 06/01 23:46
Weekly Report: what happened at SBMFF last week (0525-0529)?
Weekly Report · 06/01 10:11
Sino Biopharm’s LM-302 Gastric Cancer Data Pave Way for Chemo‑Free Phase III Trial
TipRanks · 05/31 22:37
Sino Biopharm Showcases Promising Phase I Data for Novel EGFR/c-Met ADC at ASCO 2026
TipRanks · 05/31 22:37
Sino Biopharm Reports Landmark Phase III Win for Benmelstobart Combo in Lung Cancer
TipRanks · 05/31 22:37
Sino Biopharm Wins China-Wide Approval for Opioid-Induced Constipation Drug
TipRanks · 05/29 10:02
More
Webull provides a variety of real-time SBMFF stock news. You can receive the latest news about Sino Biopharmaceutical Limited through multiple platforms. This information may help you make smarter investment decisions.
About SBMFF
Sino Biopharmaceutical Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Modernised Chinese Medicines and Chemical Medicines segment is mainly engaged in the manufacture, sale and distribution of modernised Chinese medicine products and western medicine products. The Investment segment is mainly engaged in the long term investments business. The Others segment is mainly engaged in the related healthcare and hospital business.